Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy

被引:0
|
作者
Derbala, Mohamed H.
Hajjar, Joud
Stephen, Bettzy
Gurses, Serdar A.
Kwiatkowski, Evan
Budde, Petra
Zucht, Hans-Dieter
Brautigam, Manuel
Schubert, Ann-Sophie
Ahangarianabhari, Behnaz
Rodriguez, Enedelia
Gouda, Mohamed
Castillo, Lilibeth
Zarifa, Abdulrazzak
How, Jeffrey A.
Moyers, Justin T.
Hong, David S.
Meric-Bernstam, Funda
Naing, Aung
机构
关键词
D O I
10.1158/1538-7445.AM2024-5141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5141
引用
收藏
页数:3
相关论文
共 50 条
  • [3] Autoantibody-positivity Before Treatment Is Associated with Immune-related Adverse Events in Melanoma Patients Treated with anti-PD-1
    van Wesemael, Tineke
    Borgers, Jessica
    Gelderman, Kyra
    Verdegaal, Els
    Korse, C. M.
    Welters, M. J. P.
    Kapiteijn, Ellen
    van Houdt, W. J.
    van der Burg, Sjoerd
    Toes, Rene
    Thienen, J. V.
    Haanen, John
    van der Woude, Diane
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4977 - 4979
  • [5] Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1)
    Cybulska-Stopa, Bozena
    Kaminska-Winciorek, Grazyna
    Dyduch, Grzegorz
    MELANOMA RESEARCH, 2020, 30 (06) : 619 - 624
  • [6] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    John A. McCulloch
    Diwakar Davar
    Richard R. Rodrigues
    Jonathan H. Badger
    Jennifer R. Fang
    Alicia M. Cole
    Ascharya K. Balaji
    Marie Vetizou
    Stephanie M. Prescott
    Miriam R. Fernandes
    Raquel G. F. Costa
    Wuxing Yuan
    Rosalba Salcedo
    Erol Bahadiroglu
    Soumen Roy
    Richelle N. DeBlasio
    Robert M. Morrison
    Joe-Marc Chauvin
    Quanquan Ding
    Bochra Zidi
    Ava Lowin
    Saranya Chakka
    Wentao Gao
    Ornella Pagliano
    Scarlett J. Ernst
    Amy Rose
    Nolan K. Newman
    Andrey Morgun
    Hassane M. Zarour
    Giorgio Trinchieri
    Amiran K. Dzutsev
    Nature Medicine, 2022, 28 : 545 - 556
  • [7] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    McCulloch, John A.
    Davar, Diwakar
    Rodrigues, Richard R.
    Badger, Jonathan H.
    Fang, Jennifer R.
    Cole, Alicia M.
    Balaji, Ascharya K.
    Vetizou, Marie
    Prescott, Stephanie M.
    Fernandes, Miriam R.
    Costa, Raquel G. F.
    Yuan, Wuxing
    Salcedo, Rosalba
    Bahadiroglu, Erol
    Roy, Soumen
    DeBlasio, Richelle N.
    Morrison, Robert M.
    Chauvin, Joe-Marc
    Ding, Quanquan
    Zidi, Bochra
    Lowin, Ava
    Chakka, Saranya
    Gao, Wentao
    Pagliano, Ornella
    Ernst, Scarlett J.
    Rose, Amy
    Newman, Nolan K.
    Morgun, Andrey
    Zarour, Hassane M.
    Trinchieri, Giorgio
    Dzutsev, Amiran K.
    NATURE MEDICINE, 2022, 28 (03) : 545 - +
  • [8] Cutaneous immune-related adverse events in 1,857 patients treated with anti-PD-1 therapy at an academic center
    Le, T.
    Kaul, S.
    Cappelli, L.
    Naidoo, J.
    Kwatra, S. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S108 - S108
  • [9] RISK FACTORS OF IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS TREATED WITH ANTI-PD-1 ANTIBODY PEMBROLIZUMAB
    Eun, Y.
    Kim, I. Y.
    Kim, H.
    Ahn, J. K.
    Park, E. -J.
    Hwang, J.
    Jeong, H.
    Chai, J. Y.
    Cha, H. -S.
    Koh, E. -M.
    Lee, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1205 - 1205
  • [10] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Eun, Yeonghee
    Kim, In Young
    Sun, Jong-Mu
    Lee, Jeeyun
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Kim, Hyungjin
    Lee, Jaejoon
    SCIENTIFIC REPORTS, 2019, 9 (1)